Background: Intake of long-chain n-3 polyunsaturated fatty acids (n-3 PUFA), including docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), is associated with a lower risk of atherosclerotic cardiovascular events, particularly acute myocardial infarction (AMI). However, limited data are available regarding the association between serum n-3 PUFA levels and heart failure (HF) events in survivors of AMI. Methods and Results: We evaluated whether serum DHA and EPA levels were associated with HF-free survival and HF hospitalization rates after AMI. A total of 712 patients were divided into 3 groups according to their tertile serum levels of DHA and EPA (Low, Middle, and High). Propensity-score-stratified Cox regression analysis revealed t...
BACKGROUND: Trials have shown a beneficial effect of n-3 polyunsaturated fatty acids in patients wit...
AIMS: In the last few years, n-3 polyunsaturated acids (PUFAs) have been extensively studied for the...
Background: Heart failure is a major risk factor for cardiovascular mortality, for which n-3 fatty a...
Background The cardiovascular benefit from n-3 polyunsaturated fatty acids (PUFAs) after acute myoca...
BACKGROUND: Although omega-3 polyunsaturated fatty acids are known to have beneficial effects on car...
Circulating polyunsaturated fatty acid (PUFA) levels are associated with clinical outcomes in cardio...
Circulating polyunsaturated fatty acid (PUFA) levels are associated with clinical outcomes in cardio...
Background: Dietary omega-3 eicosapentaenoic acid (EPA) has multiple cardioprotective properties. Th...
Several epidemiological and experimental studies suggest that n-3 polyunsaturated fatty acids (PUFA)...
Background: High intake of marine n-3 polyunsaturated fatty acids (PUFA) has been associated with re...
Background: Several epidemiological and experimental studies suggest that n-3 polyunsaturated fatty ...
Clinical trials studying the efficacy of n-3 polyunsaturated fatty acids (PUFA) in reducing adverse ...
AbstractBackgroundIntake of n-3 polyunsaturated fatty acids (n-3 PUFAs) lowers the risk of atheroscl...
In previous studies, low blood levels of n-3 fatty acids (FA) have been associated with increased ri...
Background - Results from prospective cohort studies and randomized, controlled trials have provided...
BACKGROUND: Trials have shown a beneficial effect of n-3 polyunsaturated fatty acids in patients wit...
AIMS: In the last few years, n-3 polyunsaturated acids (PUFAs) have been extensively studied for the...
Background: Heart failure is a major risk factor for cardiovascular mortality, for which n-3 fatty a...
Background The cardiovascular benefit from n-3 polyunsaturated fatty acids (PUFAs) after acute myoca...
BACKGROUND: Although omega-3 polyunsaturated fatty acids are known to have beneficial effects on car...
Circulating polyunsaturated fatty acid (PUFA) levels are associated with clinical outcomes in cardio...
Circulating polyunsaturated fatty acid (PUFA) levels are associated with clinical outcomes in cardio...
Background: Dietary omega-3 eicosapentaenoic acid (EPA) has multiple cardioprotective properties. Th...
Several epidemiological and experimental studies suggest that n-3 polyunsaturated fatty acids (PUFA)...
Background: High intake of marine n-3 polyunsaturated fatty acids (PUFA) has been associated with re...
Background: Several epidemiological and experimental studies suggest that n-3 polyunsaturated fatty ...
Clinical trials studying the efficacy of n-3 polyunsaturated fatty acids (PUFA) in reducing adverse ...
AbstractBackgroundIntake of n-3 polyunsaturated fatty acids (n-3 PUFAs) lowers the risk of atheroscl...
In previous studies, low blood levels of n-3 fatty acids (FA) have been associated with increased ri...
Background - Results from prospective cohort studies and randomized, controlled trials have provided...
BACKGROUND: Trials have shown a beneficial effect of n-3 polyunsaturated fatty acids in patients wit...
AIMS: In the last few years, n-3 polyunsaturated acids (PUFAs) have been extensively studied for the...
Background: Heart failure is a major risk factor for cardiovascular mortality, for which n-3 fatty a...